• LAST PRICE
    0.0001
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0001
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0001
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPUMD
ProUroCare Medical Inc
1.9K
0.0x
---
United StatesCOTI
Coretag Inc
940.0
0.0x
---
United StatesBLFE
Biolife Sciences Inc
3.2K
0.0x
---
United StatesNNMX
Nanomix Corp
4.9K
0.0x
---
United StatesSCIE
SpectraScience Inc
4.8K
0.0x
---
United StatesQTXB
Quantrx Biomedical Corp
118.0K
-0.5x
---
As of 2024-10-18

Company Information

ProUroCare Medical Inc. (ProUroCare) is engaged in the business of developing products for the detection and characterization of prostate disease. The Company is focused on its product, prostate mechanical imaging device called the ProUroScan System. The ProUroScan is an imaging system that is designed to produce an elasticity image of the prostate as an adjunctive aid in visualizing and documenting abnormalities of the prostate that have been detected by a digital rectal examination (DRE). The ProUroScan uses an array of sensors mounted on a rectal probe, a central processing unit, and software and image construction algorithms to provide a real time color image of abnormalities in the prostate. In addition, it provides mechanical or elasticity imaging, which refers to a non-invasive analysis of tissue movement and displacement. The Company’s product also provides two-and three-dimensional prostate images.

Contact Information

Headquarters
SUITE 101, 6440 FLYING CLOUD DRIVEEDEN PRAIRIE, MN, United States 55344
Phone
952-698-1161
Fax
952-698-4499

Executives

Chairman of the Board
James Davis
Interim Chief Executive Officer, Director
Stanton Myrum
Chief Financial Officer, Secretary
Alan Shuler
Director
David Kaysen
Independent Director
Scott Smith

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.9K
Revenue (TTM)
$0.00
Shares Outstanding
18.6M
ProUroCare Medical Inc does not pay a dividend.
Beta
---
EPS
$-0.12
Book Value
$-0.21
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.